Table 2 Topological indices of anti-arrhythmia drugs.
From: Evaluation of antiarrhythmia drug through QSPR modeling and multi criteria decision analysis
Drugs | \(M_1(\varGamma )\) | \(M_2(\varGamma )\) | \(NM_1(\varGamma )\) | \(NM_2(\varGamma )\) | \(NSS(\varGamma )\) | \(NH(\varGamma )\) |
|---|---|---|---|---|---|---|
Metoprolol | 84 | 89 | 178 | 427 | 28.77 | 4.24 |
Atenolol | 86 | 91 | 162 | 395 | 25.9 | 3.75 |
Bisoprolol | 102 | 107 | 214 | 505 | 34.79 | 5.07 |
Propranolol | 92 | 103 | 206 | 547 | 31.63 | 4.07 |
Sotalol | 86 | 92 | 181 | 461 | 28.21 | 3.69 |
Amiodarone | 156 | 184 | 368 | 1074 | 53.72 | 6.46 |
Carvedilol | 154 | 180 | 360 | 1029 | 53.58 | 6.41 |
Flecainide | 140 | 153 | 303 | 803 | 46.42 | 5.69 |
Propafenone | 116 | 128 | 256 | 649 | 40.18 | 5.56 |
Timolol | 104 | 115 | 230 | 614 | 35.13 | 4.36 |
